Provide Current Location
Sign in to see your saved address

GLENMARK

Airz Fb Inhaler (120 Mdi)

₹ 656 / Piece

₹ 820

20%

Whatsapp
Facebook

⭐Important Notice⭐

* T & C Apply.
* Product MRP can be changed without prior notice.
* Product offer can be withdrawn, modified, and removed by the company without prior notice.
* Product images sometimes change based on stock availability.
* Delivery lead time can vary depending on traffic and availability.
* product availability as per location-wise stock matters.
* Please check the details of medicines Name, Strength, Quantity, Batch No., Expiry date, etc., with your prescription
Please understand that after accepting the medicines, we shall not be liable or responsible.
* Batch No., MRP, Expiry date, Image, description can be changed as per notice, etc.
* Any suppor,supportt please call/Whatsapp us ‪+91 8101099110‬.

Join WhatsApp Channel For Offer & Updates:-  https://whatsapp.com/channel/0029VagZBQk4yltHfZOmXQ0g

Discover the Airz Fb Inhaler (120 MDI) by GLENMARK

Your trusted partner for respiratory health, brought to you by Medosee Pharmacy. The Airz Fb Inhaler (120 MDI) is designed to provide effective relief and management of respiratory conditions, ensuring you breathe easier and live better. Backed by the trusted expertise of GLENMARK, this inhaler is a reliable solution for managing asthma and other chronic respiratory issues.

Why Choose the Airz Fb Inhaler?

  • Trusted Brand: Manufactured by GLENMARK, a leading name in pharmaceutical innovation.
  • Ease of Use: Compact and portable design, making it convenient to carry and use anytime, anywhere.
  • Effective Relief: Delivers precise medication doses to help alleviate symptoms and improve respiratory function.
  • High Capacity: Offers up to 120 metered doses, ensuring long-lasting support for your respiratory needs.
  • Quality Assurance: Each inhaler is carefully packaged and verified for safety and efficacy.

Important Notice

At Medosee Pharmacy, customer satisfaction and transparency are our priorities. Please note the following: